Post-IPO Debt Therapeutics Companies

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Acer Therapeutics focuses on the acquisition, development, and commercialization of therapies for patients with serious rare diseases.

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

ChemoTech is an innovator in gentle cancer treatment and effective pain management.

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Irras is a commercial-stage medical technology company.

Forum Markets developing novel drugs for treating distinct inflammatory diseases.

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.